Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.

He was surprised to discover, for example, that a photo of the GSK headquarters building attracted more positive comments than a story about a community partnership. A recent example of content ...

This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosciences ...

Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse ...

Billionaire Dalio, head of the world's largest hedge fund, is considered a global authority on investing in China. The bank ...

Which company has replaced IBM as the largest employer in Research Triangle Park? And who are the top hirers in Wake, Durham, ...

Me’s genetic data may be for sale after bankruptcy. AI firms may want in—but privacy fears could make it a toxic asset.

Roche (ROG.S), opens new tab said its Chief Diversity Offices in the U.S. and at its Basel headquarters "will focus on inclusion and belonging, and responsibilities will be re-scoped accordingly".

23andMe cofounder and CEO Anne Wojcicki stepped down and the company filed for Chapter 11 bankruptcy protection, it said ...

Streamtec is on track to achieve a record-breaking £6m turnover, bolstered by new client wins. The Arbroath-based ...

CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE European Patent ...

23andMe cofounder and CEO Anne Wojcicki stepped down and the company filed for Chapter 11 bankruptcy protection, it said Sunday, capping a year-long saga that saw Wojcicki fail to convince her own ...